Company Filing History:
Years Active: 2017-2022
Title: **Antoine Ferry: Innovator in Ophthalmic Formulations**
Introduction
Antoine Ferry, a notable inventor based in Paris, France, has made significant contributions to the field of pharmaceutical formulations. With three patents to his name, he focuses on innovations that advance therapeutic applications, particularly within the realm of ophthalmic compositions.
Latest Patents
Among his latest patents, Ferry has developed a sterile formulation comprising a stable phosphorothioate oligonucleotide. This composition includes a phosphorothioate oligonucleotide and at least one fatty acid and/or emulsifying agent. The invention emphasizes a sterile condition for the composition, which incorporates at least one agent with a thiol group and at least one phosphate compound. This formulation shows potential therapeutic applications, particularly in ophthalmology.
Another significant patent by Ferry mirrors the details of the first. It also encompasses a sterile formulation consisting of a phosphorothioate oligonucleotide alongside a fatty acid and/or emulsifying agent, reinforcing its applicability in creating ophthalmic compositions. Both patents highlight his expertise in developing stable, innovative solutions for medical use.
Career Highlights
Antoine Ferry is currently associated with Gene Signal International SA, where his research and inventions play a crucial role in advancing the company's mission. His commitment to innovation in the pharmaceutical industry is commendable, as he continuously seeks to improve existing formulations and address unmet medical needs.
Collaborations
Throughout his career, Ferry has collaborated with esteemed colleagues, including Eric Viaud and Carla Missiaen. These partnerships have allowed for the sharing of knowledge and expertise, fostering an environment of innovation within Gene Signal International SA.
Conclusion
Antoine Ferry stands out as a dedicated inventor in the pharmaceutical domain, particularly in the development of sterile ophthalmic formulations. His work, backed by three patents, exemplifies the spirit of innovation that drives advancements in medical therapies. As he continues to collaborate with industry experts, his contributions are sure to enhance the quality of treatments available in the market.